IgE |
n=66
|
n=240
|
n=271
|
n=149
|
n=726
| |
Total IgE (IU/ml)4-160
| 27.2 | 31.0 | 29.0 | 33.9 | 30.4 (4.6) | 1.0 |
Prevalence of specific IgE (cat, mite or pollen) | 22.7% | 21.3% | 24.0% | 23.5% | 22.9% | 0.7 |
Lung function |
n=65
|
n=242
|
n=275
|
n=151
|
n=733
| |
FEV1(l)4-165
| 3.11 | 3.08 | 3.09 | 3.14 | 3.10 (0.62) | 0.64-168
|
FVC (l)4-165
| 4.30 | 4.26 | 4.27 | 4.35 | 4.29 (0.73) | 0.64-168
|
FEV1/FVC4-165
| 0.722 | 0.728 | 0.724 | 0.727 | 0.725 (0.108) | 0.84-168 |
Respiratory symptoms and disease |
n=87
|
n=302
|
n=334
|
n=189
|
n=912
| |
Wheeze | 13.8% | 12.3% | 12.0% | 9.5%% | 11.7% | 0.8 |
Productive cough | 4.6% | 5.6% | 4.8% | 2.1% | 4.5% | 0.7 |
Obstructive airways disease | 17.2% | 17.9% | 20.7% | 14.3% | 18.1% | 1.0 |